|
1
|
Newman JR, Connolly TM, Illing EA, Kilgore
ML, Locher JL and Carroll WR: Survival trends in hypopharyngeal
cancer: A population-based review. Laryngoscope. 125:624–629. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan JY and Wei WI: Current management
strategy of hypopharyngeal carcinoma. Auris Nasus Larynx. 40:2–6.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qian Y, Liu D, Cao S, Tao Y, Wei D, Li W,
Li G, Pan X and Lei D: Upregulation of the long noncoding RNA UCA1
affects the proliferation, invasion, and survival of hypopharyngeal
carcinoma. Mol Cancer. 16:682017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu S, Hui L, Yang N, Wang Y, Zhao N and
Jiang XJ: Upregulation of microRNA-194-5p inhibits hypopharyngeal
carcinoma cell proliferation, migration and invasion by targeting
SMURF1 via the mTOR signaling pathway. Int J Oncol. 54:1245–1255.
2019.PubMed/NCBI
|
|
5
|
Chen L, Feng PM, Zhu X, He SX, Duan JL and
Zhou D: Long non-coding RNA Malat1 promotes neurite outgrowth
through activation of ERK/MAPK signalling pathway in N2a cells. J
Cell Mol Med. 20:2102–2110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gong Y, Zhu Y, Zhu B, Si X, Heng D, Tang
Y, Sun X and Lin L: LncRNA MALAT1 is up-regulated in diabetic
gastroparesis and involved in high-glucose-induced cellular
processes in human gastric smooth muscle cells. Biochem Biophys Res
Commun. 496:401–406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo D, Ma J, Yan L, Li T, Li Z, Han X and
Shui S: Down-regulation of Lncrna MALAT1 attenuates neuronal cell
death through suppressing Beclin1-dependent autophagy by regulating
Mir-30a in cerebral ischemic stroke. Cell Physiol Biochem.
43:182–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu X, An J, Hua Y, Li Z, Yan N, Fan W and
Su C: MicroRNA-194 regulates keratinocyte proliferation and
differentiation by targeting Grainyhead-like 2 in psoriasis. Pathol
Res Pract. 213:89–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Peng WX, Mo YY and Luo D:
MALAT1-mediated tumorigenesis. Front Biosci (Landmark Ed).
22:66–80. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma J, Wu K, Liu K and Miao R: Effects of
MALAT1 on proliferation and apo- ptosis of human non-small cell
lung cancer A549 cells in vitro and tumor xenograft growth in vivo
by modulating autophagy. Cancer Biomark. 22:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang CJ, Shi SB, Tian J, Xu J and Niu ZX:
lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the
efficacy of GEM based chemotherapy in first-line treatment of
pancreatic cancer patients. Oncotarget. 8:95108–95115.
2017.PubMed/NCBI
|
|
12
|
Wang J and Sun G: FOXO1-MALAT1-miR-26a-5p
feedback loop mediates proliferation and migration in osteosarcoma
cells. Oncol Res. 25:1517–1527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Yao H, Wang K and Liu X: Long
non-coding RNA MALAT1 regulates ZEB1 expression by sponging
miR-143-3p and promotes hepatocellular carcinoma progression. J
Cell Biochem. 118:4836–4843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumour Biol. 36:2947–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiong Z, Wang L, Wang Q and Yuan Y: LncRNA
MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting
SOX2. J Cell Mol Med. May 29–2018.(Epub ahead of print). View Article : Google Scholar
|
|
16
|
Latouche C, Natoli A, Reddy-Luthmoodoo M,
Heywood SE, Armitage JA and Kingwell BA: MicroRNA-194 modulates
glucose metabolism and its skeletal muscle expression is reduced in
diabetes. PLoS One. 11:e01551082016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia Y, Guan M, Zheng Z, Zhang Q, Tang C,
Xu W, Xiao Z, Wang L and Xue Y: miRNAs in urine extracellular
vesicles as predictors of early-stage diabetic nephropathy. J
Diabetes Res. 2016:79327652016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong L, Sun M, Jiang Z, Li L and Lu B:
MicroRNA-194 inhibits lipopolysaccharide-induced inflammatory
response in nucleus pulposus cells of the intervertebral disc by
targeting TNF receptor-associated factor 6 (TRAF6). Med Sci Monit.
24:3056–3067. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Yu Y, Fan S and Luo L: Knockdown
of long non-coding RNA NEAT1 inhibits proliferation and invasion
and induces apoptosis of osteosarcoma by inhibiting miR-194
expression. Yonsei Med J. 58:1092–1100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Wei C, Li J, Liu J and Qu J:
MicroRNA-194 represses glioma cell epithelialtomesenchymal
transition by targeting Bmi1. Oncol Rep. 37:1593–1600. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang ZH, Ren LL, Zheng P, Zheng HM, Yu YN,
Wang JL, Lin YW, Chen YX, Ge ZZ, Chen XY, et al: miR-194 as a
predictor for adenoma recurrence in patients with advanced
colorectal adenoma after polypectomy. Cancer Prev Res (Phila).
7:607–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mi J, Zou Y, Lin X, Lu J, Liu X, Zhao H,
Ye X, Hu H, Jiang B, Han B, et al: Dysregulation of the
miR-194-CUL4B negative feedback loop drives tumorigenesis in
non-small-cell lung carcinoma. Mol Oncol. 11:305–319. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Zhuang Q and Cui L: MiR-194
inhibits cell proliferation and invasion via repression of RAP2B in
bladder cancer. Biomed Pharmacother. 80:268–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
26
|
Zhang M, Liu J, Li M, Zhang S, Lu Y, Liang
Y, Zhao K and Li Y: Insulin-like growth factor 1/insulin-like
growth factor 1 receptor signaling protects against cell apoptosis
through the PI3K/AKT pathway in glioblastoma cells. Exp Ther Med.
16:1477–1482. 2018.PubMed/NCBI
|
|
27
|
Guan J, Zhou Y, Mao F, Lin Y, Shen S,
Zhang Y and Sun Q: MicroRNA-320a suppresses tumor cell growth and
invasion of human breast cancer by targeting insulin-like growth
factor 1 receptor. Oncol Rep. 40:849–858. 2018.PubMed/NCBI
|
|
28
|
Moroishi T, Hansen CG and Guan KL: The
emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 15:73–79.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song S, Honjo S, Jin J, Chang SS, Scott
AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, et
al: The hippo coactivator YAP1 mediates EGFR overexpression and
confers chemoresistance in esophageal cancer. Clin Cancer Res.
21:2580–2590. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu Y, Cai R, Zhang C, Xue Y, Pan Y, Wang J
and Zhang Z: miR-132-3p boosts caveolae-mediated transcellular
transport in glioma endothelial cells by targeting
PTEN/PI3K/PKB/Src/Cav-1 signaling pathway. FASEB J. 33:441–454.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xue W, Chen J, Liu X, Gong W, Zheng J, Guo
X, Liu Y, Liu L, Ma J, Wang P, et al: PVT1 regulates the malignant
behaviors of human glioma cells by targeting miR-190a-5p and
miR-488-3p. Biochim Biophys Acta Mol Basis Dis. 1864:1783–1794.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Sun J and Yang F: The role of long
non-coding RNA H19 in breast cancer. Oncol Lett. 19:7–16.
2020.PubMed/NCBI
|
|
34
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee NK, Lee JH, Ivan C, Ling H, Zhang X,
Park CH, Calin GA and Lee SK: MALAT1 promoted invasiveness of
gastric adenocarcinoma. BMC Cancer. 17:462017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pa M, Naizaer G, Seyiti A and Kuerbang G:
Long noncoding RNA MALAT1 functions as a sponge of MiR-200c in
ovarian cancer. Oncol Res. Sep 11–2017.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang SM and Hu WW: Long non-coding RNA
MALAT1 promotes oral squamous cell carcinoma development via
microRNA-125b/STAT3 axis. J Cell Physiol. 233:3384–3396. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Handa H, Kuroda Y, Kimura K, Masuda Y,
Hattori H, Alkebsi L, Matsumoto M, Kasamatsu T, Kobayashi N, Tahara
KI, et al: Long non-coding RNA MALAT1 is an inducible stress
response gene associated with extramedullary spread and poor
prognosis of multiple myeloma. Br J Haematol. 179:449–460. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fang Z, Zhang S, Wang Y, Shen S, Wang F,
Hao Y, Li Y, Zhang B, Zhou Y and Yang H: Long non-coding RNA
MALAT-1 modulates metastatic potential of tongue squamous cell
carcinomas partially through the regulation of small proline rich
proteins. BMC Cancer. 16:7062016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li L, Chen H, Gao Y, Wang YW, Zhang GQ,
Pan SH, Ji L, Kong R, Wang G, Jia YH, et al: Long noncoding RNA
MALAT1 promotes aggressive pancreatic cancer proliferation and
metastasis via the stimulation of autophagy. Mol Cancer Ther.
15:2232–2243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang C, Yu Z, Yang H and Lin Y: Increased
MALAT1 expression predicts poor prognosis in esophageal cancer
patients. Biomed Pharmacother. 83:8–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miao Y, Fan R, Chen L and Qian H: Clinical
significance of long non-coding RNA MALAT1 expression in tissue and
serum of breast cancer. Ann Clin Lab Sci. 46:418–424.
2016.PubMed/NCBI
|
|
43
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
|
44
|
Li H, Yuan X, Yan D, Li D, Guan F, Dong Y,
Wang H, Liu X and Yang B: Long non-coding RNA MALAT1 decreases the
sensitivity of resistant glioblastoma cell lines to temozolomide.
Cell Physiol Biochem. 42:1192–1201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao X, Hou Y, Tuo Z and Wei F:
Application values of miR-194 and miR-29 in the diagnosis and
prognosis of gastric cancer. Exp Ther Med. 15:4179–4184.
2018.PubMed/NCBI
|
|
46
|
Cai Y, Yan P, Zhang G, Yang W, Wang H and
Cheng X: Long non-coding RNA TP73-AS1 sponges miR-194 to promote
colorectal cancer cell proliferation, migration and invasion via
up-regulating TGFα. Cancer Biomark. 23:145–156. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qu F and Cao P: Long noncoding RNA SOX2OT
contributes to gastric cancer progression by sponging miR-194-5p
from AKT2. Exp Cell Res. 369:187–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen Y, Wei H, Liu Y and Zheng S:
Promotional effect of microRNA-194 on breast cancer cells via
targeting F-box/WD repeat-containing protein 7. Oncol Lett.
15:4439–4444. 2018.PubMed/NCBI
|
|
49
|
Jiang Y, Chen J and Chen G: Long noncoding
RNA IRAIN acts as tumor suppressor via miR-125b in multiple
myeloma. Oncol Lett. 18:6787–6794. 2019.PubMed/NCBI
|
|
50
|
Sun B, Liu C, Li H, Zhang L, Luo G, Liang
S and Lü M: Research progress on the interactions between long
non-coding RNAs and microRNAs in human cancer. Oncol Lett.
19:595–605. 2020.PubMed/NCBI
|
|
51
|
Yan W, Wu Q, Yao W, Li Y, Liu Y, Yuan J,
Han R, Yang J, Ji X and Ni C: MiR-503 modulates
epithelial-mesenchymal transition in silica-induced pulmonary
fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1. Sci
Rep. 7:113132017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stavast CJ and Erkeland SJ: The
non-canonical aspects of MicroRNAs: Many roads to gene regulation.
Cells. 8(pii): E14652019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang B, Li Y, Hou D, Shi Q, Yang S and Li
Q: MicroRNA-375 inhibits growth and enhances radiosensitivity in
oral squamous cell carcinoma by targeting insulin like growth
factor 1 receptor. Cell Physiol Biochem. 42:2105–2117. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dale OT, Aleksic T, Shah KA, Han C,
Mehanna H, Rapozo DC, Sheard JD, Goodyear P, Upile NS, Robinson M,
et al: IGF-1R expression is associated with HPV-negative status and
adverse survival in head and neck squamous cell cancer.
Carcinogenesis. 36:648–655. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kato H, Sekine Y, Furuya Y, Miyazawa Y,
Koike H and Suzuki K: Metformin inhibits the proliferation of human
prostate cancer PC-3 cells via the downregulation of insulin-like
growth factor 1 receptor. Biochem Biophys Res Commun. 461:115–121.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Deng WY, Li N, Wan XB, Luo SX and Zhang
YW: Phosphorylated insulin-like growth factor-1 receptor expression
predicts poor prognosis of Chinese patients with gastric cancer.
Med Oncol. 31:1412014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu J, Zhang S, Shan J, Hu Z, Liu X, Chen
L, Ren X, Yao L, Sheng H, Li L, et al: Elevated HMGA2 expression is
associated with cancer aggressiveness and predicts poor outcome in
breast cancer. Cancer Lett. 376:284–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Luo J, Wu J, Li Z, Qin H, Wang B, Wong TS,
Yang W, Fu QL and Lei W: miR-375 suppresses IGF1R expression and
contributes to inhibition of cell progression in laryngeal squamous
cell carcinoma. Biomed Res Int. 2014:3745982014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhao H and Gu X: Silencing of insulin-like
growth factor-1 receptor enhances the radiation sensitivity of
human esophageal squamous cell carcinoma in vitro and in vivo.
World J Surg Oncol. 12:3252014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Eun YG, Lee D, Lee YC, Sohn BH, Kim EH,
Yim SY, Kwon KH and Lee JS: Clinical significance of YAP1
activation in head and neck squamous cell carcinoma. Oncotarget.
8:111130–111143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jerhammar F, Johansson AC, Ceder R,
Welander J, Jansson A, Grafström RC, Söderkvist P and Roberg K:
YAP1 is a potential biomarker for cetuximab resistance in head and
neck cancer. Oral Oncol. 50:832–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
